Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

Multiple Sclerosis Journal

Volumn 20, Issue 3, 2014, Pages 331-337

  Yonezu, Tadahiro ^a   Ito, Shoichi ^a   Mori, Masahiro ^a   Ogawa, Yoshitsugu ^b   Makino, Takahiro ^c   Uzawa, Akiyuki ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Chiba Cardiovascular Center   (Japan)

^c Kashima Rosai Hospital   (Japan)

Author keywords

bright; MRI; multiple sclerosis; neuroimaging; Neuromyelitis optica; spinal cord; spotty

Indexed keywords

GADOLINIUM; AQUAPORIN 4 ANTIBODY; CYCLOSPORIN; FINGOLIMOD; INTERFERON BETA SERINE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; SPINE RADIOGRAPHY; ANTIBODY TITER; BRIGHT SPOTTY LESION; DISEASE DURATION; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INCIDENCE; LONGITUDINALLY EXTENSIVE SPINAL CORD LESION; MAJOR CLINICAL STUDY; NEUROIMAGING; ONSET AGE; RETROSPECTIVE STUDY; SPINAL CORD LESION;

BRIGHT; MRI; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROMYELITIS OPTICA; SPINAL CORD; SPOTTY;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; RETROSPECTIVE STUDIES; SPINAL CORD;

EID: 84895749264     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513495581     Document Type: Article

References (20)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuronyelitis optica: Distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112 (Pubitemid 39626806)
2. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 ; 202: 473-477 (Pubitemid 41186945)
3. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Treat Options Neurol. 2005 ; 7: 173-182 (Pubitemid 40894929)
4. Papeix C, Vidal JS, de Seze J, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler. 2007 ; 13: 256-259 (Pubitemid 46592781)
5. Uzawa A, Mori M, Hyakawa S, et al. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol. 2010 ; 17: 672-676
6. Palace J, Leite MI, Nairne A, et al. Interferon Beta treatment in neuromyelitis optica: Increase in relapses and aquaporin 4 antibody titers. Arch Neurol. 2010 ; 67: 1016-1017
7. Min JH, Kim BJ, Lee KH. Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler. 2012 ; 18: 113-115
8. Kleiter I, Hellwig K, Berthele A, et al. Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol. 2012 ; 69: 239-245
9. Jacob A, Hutchinson M, Elsone L, et al. Dose natalizumab therapy worsen neuromyelitis optica?. Neurology. 2012 ; 79: 1065-1066
10. Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis. Brain. 2007 ; 130: 1224-1234 (Pubitemid 47355951)
11. Wingerchuk DM. Neuromyelitis optica: New findings on pathogenesis. Int Rev Neurobiol. 2007 ; 79: 665-688
12. Cabrera-Gomez JA, Quevedo-Sotolongo L, Gonzalez-Quevedo A, et al. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler. 2007 ; 13: 186-192 (Pubitemid 46592770)
13. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 ; 63: 390-396
14. Cabrera-Gomez JA, Kister I. Conventional brain MRI in neuromyelitis optica. Eur J Neurol. 2012 ; 19: 812-819
15. Ito S, Mori M, Makino T, et al. "Cloud-like Enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009 ; 66: 425-428
16. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489 (Pubitemid 43958540)
17. Nakamura M, Miyazawa I, Fujihara K, et al. Preferential spinal central gray matter involvement in neuromyelitis optica. J Neurol. 2008 ; 255: 163-170
18. Hayakawa S, Mori M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol. 2008 ; 196: 181-187
19. Ann Neurol. Chris HP Stephen CR Gilles Edan, ed. 2005: 840-846.
20. Kampla W, Aboul-Enein F, Jecel J, et al. Spinal cord lesions in patients with neuromyelitis optica: A retrospective long-term MRI follow-up study. Eur Radiol. 2009 ; 19: 2535-2543